CASADEI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 291
EU - Europa 161
AS - Asia 62
AF - Africa 17
SA - Sud America 2
Totale 533
Nazione #
US - Stati Uniti d'America 291
SE - Svezia 43
DE - Germania 31
SG - Singapore 27
IT - Italia 24
GB - Regno Unito 20
IE - Irlanda 18
CN - Cina 15
IN - India 12
BG - Bulgaria 11
CI - Costa d'Avorio 9
TG - Togo 8
BE - Belgio 5
CH - Svizzera 4
CL - Cile 2
FR - Francia 2
ID - Indonesia 2
JO - Giordania 2
TR - Turchia 2
AT - Austria 1
FI - Finlandia 1
GR - Grecia 1
JP - Giappone 1
PH - Filippine 1
Totale 533
Città #
Chandler 61
Fairfield 26
Ashburn 25
Singapore 23
Dublin 18
Southend 18
Princeton 16
Houston 15
Wilmington 15
Ann Arbor 12
Cambridge 12
Sofia 11
Abidjan 9
Seattle 9
Lomé 8
Turin 7
Montescudo 6
Brussels 5
Santa Clara 5
Berlin 4
Des Moines 4
New York 4
Woodbridge 4
Bern 3
Bühl 3
Norwalk 3
San Diego 3
Amman 2
Beijing 2
Jakarta 2
Mount Pleasant 2
Munich 2
Shanghai 2
Treviso 2
Bologna 1
Chengdu 1
Chicago 1
Costa Mesa 1
Dongguan 1
Florence 1
Giovinazzo 1
Gorle 1
Haikou 1
Helsinki 1
Jiaxing 1
Katerini 1
Leawood 1
London 1
Manila 1
New Bedfont 1
Redmond 1
Redwood City 1
San Francisco 1
Shenyang 1
Taizhou 1
Vienna 1
Westminster 1
Wuhan 1
Çankaya 1
Totale 368
Nome #
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 115
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors 74
Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy 71
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives 70
The interplay between inflammation, anti-angiogenic agents, and immune checkpoint inhibitors: Perspectives for renal cell cancer treatment 68
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors 59
Plasma androgen receptor in prostate cancer 58
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study 47
Totale 562
Categoria #
all - tutte 2.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 3 4 4 4 8 2 0
2020/202179 3 0 3 24 24 4 0 1 9 4 2 5
2021/2022149 1 0 4 8 11 6 13 9 7 23 45 22
2022/2023204 11 24 10 30 17 20 4 13 44 5 14 12
2023/202449 4 8 11 3 1 13 1 3 1 2 0 2
2024/202556 10 22 16 8 0 0 0 0 0 0 0 0
Totale 562